Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

PURPOSE: We and others have reported that adding adefovir dipivoxil (adefovir) to lamivudine results in virological and biochemical improvement in cases of lamivudine resistance. The current study assessed the efficacy and safety of combined therapy after 104 weeks of combined treatment and analyzed...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Perrillo, Robert P., Hann, Hie-Won, Schiff, Eugene, Mutimer, David, Willems, Bernard, Leung, Nancy, Lee, William M., Dixon, Susan, Woessner, Mary, Brosgart, Carol L., Condreay, Lynn D., Gardner, Stephen D.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer-Verlag 2011
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090563/
https://ncbi.nlm.nih.gov/pubmed/21484148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9228-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы